{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:02:13Z","timestamp":1791846133330,"version":"4.3.4"},"reference-count":132,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Immunopathol Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Cancer has become a major global health crisis and the second leading cause of death worldwide. With over 270 different types, it is estimated to claim 13 million lives by 2030. The complex pathophysiology of cancer, with its diverse genetic, epigenetic, and biochemical pathways, complicates the diagnostic criteria. Therapeutic approaches such as surgical interventions, radiotherapy, chemotherapy, and immunotherapy have been developed. However, the treatment is still challenging due to higher costs, toxicity, off-target effects, and comorbid conditions. Over the decades, liposomes, based on their particle size, surface charge, lipid composition, and lamellarity, have been explored for different therapeutic modalities for other cancers. They offer unique advantages, including improved drug efficacy, controlled site-specific release, enhanced cellular uptake, reduced systemic toxicity, and greater capacity to overcome tumor-induced resistance mechanisms. Researchers have explored liposomal treatment modalities for breast, lung, adenocarcinoma, ovarian, liver, fibrosarcoma, glioblastoma, and brain cancers. The tumor targeting drugs, for example, doxorubicin and paclitaxel, are delivered at the tumor microenvironment (TME) by passive and active transport, utilizing both the enhanced permeability and resistance (EPR) effect and cellular targets, for example, receptors, proteins, and organelles, in response to physical stimuli, for example, temperature, pH, fluid pressure, and nutrient and metabolic regulation. However, liposomes also face several limitations, including endosomal entrapment, heterogeneous targeting, suboptimal uptake by antigen-presenting cells (APCs), and storage instability. This review focuses on the advancements in liposomal nanocarriers for targeted cancer therapy. It emphasizes the evolution of their formulations to overcome potential limitations, making them highly tumor-specific and effective.<\/jats:p>","DOI":"10.1177\/03946320261438337","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:26:57Z","timestamp":1776853617000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy"],"prefix":"10.1177","volume":"40","author":[{"given":"Mahin","family":"Zubair Butt","sequence":"first","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Tariq","sequence":"additional","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Imran","sequence":"additional","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahood A.","family":"Al-Eidan","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzadi","family":"Mahjabeen","sequence":"additional","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seerat","family":"Fatima","sequence":"additional","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghayyas","family":"ud Din","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Brain Disease Institute (BCBDI), Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China"},{"name":"Chinese Academy of Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira","family":"Anjum","sequence":"additional","affiliation":[{"name":"Kinnaird College for Women, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Abdullatif M. Sharif","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6008-1947","authenticated-orcid":false,"given":"Wisam Nabeel","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-23-0411"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01398-5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-032221-115501"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.61704\/jpr.v24i4.pp17-24"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03705-y"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2024.11.002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211038735"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.54393\/fbt.v4i01.81"},{"issue":"2","key":"e_1_3_2_12_2","first-page":"65","article-title":"Review article evaluation of the potential of nanotechnology in enhancing drug bioavailability","volume":"3","author":"Aziz M","year":"2025","unstructured":"Aziz M, Din MSU, Gul I, et al. (2025) Review article evaluation of the potential of nanotechnology in enhancing drug bioavailability. Journal of Pharma and Biomedics 3(2): 65\u201376.","journal-title":"Journal of Pharma and Biomedics"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hybadv.2024.100264"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-49320-5"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2021.08.020"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/08982104.2015.1117489"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081310"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032643"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076615"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.963004"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.20517\/evcna.2024.19"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14201"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2021.57.1.27"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/14686996.2019.1627174"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.07.010"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111054"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmm2.12083"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05160-4"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.05.023"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2023.2268710"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030400"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10876-025-02836-9"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn304434a"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1039\/C6RA18702A"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2016-0135"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.68160"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010195"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102165"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/app15063189"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.15212\/bioi-2024-0107"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2024.2394611"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.5c03503"},{"issue":"1","key":"e_1_3_2_44_2","first-page":"932932","article-title":"EGFR signaling in colorectal carcinoma","volume":"2011","author":"Krasinskas AM","year":"2011","unstructured":"Krasinskas AM (2011) EGFR signaling in colorectal carcinoma. Pathology Research International 2011(1): 932932.","journal-title":"Pathology Research International"},{"issue":"1","key":"e_1_3_2_45_2","first-page":"852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications","volume":"2014","author":"Iqbal N","year":"2014","unstructured":"Iqbal N, Iqbal N (2014) Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications. Molecular Biology International 2014(1): 852748.","journal-title":"Molecular Biology International"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.01.016"},{"key":"e_1_3_2_47_2","first-page":"993","article-title":"Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro","volume":"8","author":"Wong BCK","year":"2014","unstructured":"Wong BCK, Zhang H, Qin L, et al. (2014) Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro. Drug Design, Development and Therapy 8: 993\u20131001.","journal-title":"Drug Design, Development and Therapy"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1021\/ar7000815"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.01.009"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2015.02.004"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.79"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2010.2393"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1188803"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2007.12.021"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9621-1"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S33541"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2014.12.002"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells7010007"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1039\/C2NR32145A"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1021\/bc5004313"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.08.001"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1450"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060910"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad6dc5"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040735"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121946"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102645"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbad045"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070966"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01383-z"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2020.1801725"},{"issue":"3","key":"e_1_3_2_72_2","first-page":"297","article-title":"Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Laura Immordino M","year":"2006","unstructured":"Laura Immordino M, Dosio F, Cattel L (2006) Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine 1(3): 297\u2013315.","journal-title":"International Journal of Nanomedicine"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-01930-9"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1039\/D3MA01060K"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063101"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b00216"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S258316"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29030636"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S130861"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7NR02193C"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115207"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.8b01510"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00736"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.07.031"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.06.024"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1039\/c2ib20108a"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1021\/nn300524f"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2023.111898"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf101"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2024.123955"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68156-6"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58312-5"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-022-00702-1"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1039\/D5NA00009B"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1039\/D5BM00786K"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-022-00215-2"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae194"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.04.004"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.2174\/0118715206265311231030102307"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02776-y"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.07.015"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106688"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.01.020"},{"issue":"1","key":"e_1_3_2_104_2","article-title":"Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer","volume":"2021","author":"Allahou LW","year":"2021","unstructured":"Allahou LW, Madani SY, Seifalian A (2021) Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. International Journal of Biomaterials 2021(1): 3041969.","journal-title":"International Journal of Biomaterials"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-025-00314-5"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1039\/D4PM00176A"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01014-w"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020490"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-021-03553-8"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.02.040"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030389"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.623760"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1039\/D2RA07863E"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.10.048"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031498"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081896"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.3390\/chemengineering9030056"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2022-0069"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-023-00455-x"},{"issue":"10","key":"e_1_3_2_120_2","first-page":"1","article-title":"Recent trends in the clinical translation of liposomal drug delivery systems: Application from conventional therapeutics to gene-based nanomedicine","volume":"15","author":"Kim YA","year":"2025","unstructured":"Kim YA, Kim H, Jang Y, et al. (2025) Recent trends in the clinical translation of liposomal drug delivery systems: Application from conventional therapeutics to gene-based nanomedicine. Cell Medicine 15(10): 1\u201317.","journal-title":"Cell Medicine"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020458"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-00902-w"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1080\/09205063.2025.2584677"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122808"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.2174\/0118715206293653240322041047"},{"key":"e_1_3_2_126_2","article-title":"Liposomal nanocarriers from concept to clinical applications","author":"Sengar A","year":"2025","unstructured":"Sengar A (2025) Liposomal nanocarriers from concept to clinical applications. Journal of Cancer Research. Epub ahead of print 11 April 2025. DOI:10.20944\/preprints202503.0837.v1.","journal-title":"Journal of Cancer Research"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-025-07286-8"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2022.1067144"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01574-1"},{"key":"e_1_3_2_130_2","first-page":"197","volume-title":"Nano Drug Delivery for Cancer Therapy: Principles and Practices","author":"Abbasi K","year":"2024","unstructured":"Abbasi K, Siddiqui K, Bano S, et al. (2024) Future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, ultrasound linked nano-cancer therapeutics, and application of exosomes-based cancer therapy. In: Khan FA (ed.) Nano Drug Delivery for Cancer Therapy: Principles and Practices. Singapore: Springer, pp.197\u2013251."},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781003334538-7"},{"issue":"2","key":"e_1_3_2_132_2","first-page":"3107","article-title":"Innovations in drug delivery: Nanoparticles, liposomes, and hydrogels as next-generation therapeutics","volume":"7","author":"Verma A","year":"2025","unstructured":"Verma A, Mehta MR (2025) Innovations in drug delivery: Nanoparticles, liposomes, and hydrogels as next-generation therapeutics. Journal of Pharmacy and Medicinal Research 7(2): 3107\u20138427.","journal-title":"Journal of Pharmacy and Medicinal Research"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1039\/D5BM01176K"}],"container-title":["International Journal of Immunopathology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320261438337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03946320261438337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320261438337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:01:17Z","timestamp":1777456877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03946320261438337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":132,"alternative-id":["10.1177\/03946320261438337"],"URL":"https:\/\/doi.org\/10.1177\/03946320261438337","relation":{},"ISSN":["0394-6320","2058-7384"],"issn-type":[{"value":"0394-6320","type":"print"},{"value":"2058-7384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"article-number":"03946320261438337"}}